Company to send 12 million doses of COVID-19 vaccine adapted to target Omicron.
Moderna is supplying Canada with 12 million COVID-19 shots specifically designed to target the Omicron variant of COVID-19.
Last year, the Canadian government entered into a supply deal with the company for supply of its COVID vaccine for 2022 and 2023.
The contract does allow for access to new adaptations of the vaccine.
Moderna and Canada have agreed to convert six million doses of the company's COVID vaccine, which targets the original virus, to an Omicron-containing bivalent one.
The country will also purchase an addition 4.5 million doses of the Omicron-targeted shot, and is moving forward with a scheduled delivery of 1.5 million shots of the bivalent vaccine.
While existing COVID-19 inoculations continue to provide protections against hospitalization and death, experts say the effectiveness of the vaccine has decreased as the virus has evolved.
Chief Public Health Officer Dr. Theresa Tam says Health Canada is still reviewing submissions for bivalent vaccines from Moderna and Pfizer.

WPS Launches New Cruiser Design
United Way Prepares for Next Fundraising Campaign
Community Grant Applications Now Available
Province Funding Oxford County Paramedics
Interview with a City Councillor - September 14th, 2026
PJHL Recap - Sept 11th and Sept 12th
Navy Vets Recap - Sept 11th and Sept 12th
Hike for Hospice Returns this Saturday
Two Road Construction Projects Start This Week
SWPH Reporting First Human Case of West Nile Virus
Crash Investigation on Airport Road
One Dead in Perth County Crash
Ingersoll Candidate Profile - Matthew Chambers
Two Arrested Following Brant Break-and-Enter Investigation
Woodstock Remembers 9/11
Terry Fox Run Returns to Woodstock
Navy Vets Announce Leadership Group
Woodstock Changes Parking Regulations
WPS Investigating Swatting Incident
Interview with the Warden - September 10th, 2026
Comments
Add a comment